<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
	<channel>
		<title>RSS Feed - Greiner Bio-One</title>
		<link>http://www.gbo.com</link>
		<description></description>
		<language>en</language>
		
			<copyright>Greiner Bio-One News</copyright>
		
		
		<generator>TYPO3 EXT:news</generator>
			
				
					<item>
						<guid>news-8331</guid>
						<pubDate>Tue, 26 Mar 2019 09:00:00 +0000</pubDate>
						<title>New Greiner Bio-One Logo</title>
						<link>https://www.gbo.com/en_FR/news-events/newsroom/news/news-detail/news/detail/News/new-greiner-bio-one-logo.html</link>
						<description>Greiner Bio-One has a new logo. The new division logo was developed with the aim of presenting Greiner AG visually more strongly as a group, without restricting the visual and perceived independence and autonomy of the divisions.</description>
						<content:encoded><![CDATA[<p class="bodytext">Kremsmünster, March 2019 – The new logos of all Greiner divisions were presented at the 150-years-anniversary gala in Kremsmünster in September 2018. The Greiner Bio-One Company logo is also being changed according to the new unified corporate guidelines from the Greiner AG. Since this change is very time-consuming and many areas and content types are affected, the change will take place in several stages over a period of up to five years.</p>
<p class="bodytext">We are proud to announce that Greiner Bio-One has now changed its logo online on the website www.gbo.com and on all existing social media channels managed by Greiner Bio-One.</p>
<p class="bodytext"><span style="font-weight: bold;">Rebranding of Greiner</span></p>
<p class="bodytext">As already announced by Greiner AG there are new wording specifications for Greiner AG since October 2018. The former Greiner Holding AG became Greiner AG and Greiner Group became Greiner. Greiner is headquartered in Kremsmünster, Austria, and has four operating divisions comprised by Greiner Packaging, Greiner Bio-One, Greiner Foam and Greiner Extrusion. Greiner is one of the leading producers of foam and processors of plastics for the packaging, furniture, sport, automotive, medical technology and pharmaceutical sectors. It also numbers among the top manufacturers of extrusion lines, tools and complete profile extrusion plants.</p>]]></content:encoded>
					</item>
				
					<item>
						<guid>news-6952</guid>
						<pubDate>Wed, 11 Oct 2017 09:07:00 +0000</pubDate>
						<title>Greiner Bio-One opens Site Expansion in Kremsmünster</title>
						<link>https://www.gbo.com/en_FR/news-events/newsroom/news/news-detail/news/detail/News/greiner-bio-one-opens-site-expansion-in-kremsmuenster.html</link>
						<description>Today, the expansion to Greiner Bio-One’s headquarters was officially opened following a construction period of just 16 months. With an investment amount of 10 million euros, the expansion at the Kremsmünster site in Austria represents a clear commitment to the region. The new laboratory facilities have nearly tripled the available office space and optimized workflows within the organization. The opening coincided with celebrations for the 25th anniversary of Greiner Bio-One’s headquarters at the site. </description>
						<content:encoded><![CDATA[<p class="bodytext"><span style="font-weight: bold;">Kremsmünster, October 20, 2017.</span> Greiner Bio-One is on course for success and is continually growing. Today, guests from business and politics as well as employees and their families celebrated the opening of the expanded company building. The opening also coincided with the 25th anniversary celebration of the Greiner Bio-One Group’s headquarters in Kremsmünster. “We had reached the limits of our space capacity with the old building. But we have now expanded from about 2,000 m² to 5,900 m²,” said Rainer Perneker, Divisional Manager of Greiner Bio-One. During the 21-month project period, from the construction negotiations to move-in, the office and laboratory areas were nearly tripled under the direction of architectural firm Schmid+Leitner and now offer space for 185 workstations. A total of 10 million euros was invested in the expansion of the site. During the ceremony, Deputy State Governor Dr. Michael Strugl underscored the importance of flagship companies for Upper Austria as a business location. “I’m delighted that a leading international company such as Greiner Bio-One is continuing to expand its company headquarters here in Upper Austria. The medical technology sector is a promising growth market for the future with great investment potential. The investment by Greiner Bio-One is strengthening Upper Austria’s position as a destination location for medical technology. It will also create jobs and boost the competitiveness of our state.”</p>
<p class="bodytext"><span class="highlighted">Improved workflows and communication</span></p>
<p class="bodytext">Employees moved into their new offices in the first two weeks of October. “The spacious, bright design of the offices, meeting rooms, and meet-up zones really makes a fantastic difference in my daily work,” said Doris Gintner, a Greiner Bio-One employee, of her new workplace.Departments that were formerly situated at a considerable distance from one another within a building, and sometimes even located at different sites, have now been merged at the organizational level into a single building. “This allows for optimized workflows, shorter communication channels, and greater efficiency during the implementation of projects. The laboratory will also be moved from Rainbach to Kremsmünster to leverage these same benefits,” said Perneker.&nbsp;<br /><br /><span class="highlighted">Sustainable investment</span></p>
<p class="bodytext">The new company building stands out not just for its modern design, but also for its highly efficient use of resources. “We see taking active responsibility for people and the environment as one of our most important duties. If we want to continue to be successful in the future, we need to focus on sustainability in everything we do. This conviction is also reflected in the design and implementation of our site expansion,” noted Axel Kühner, CEO of the Greiner Group.&nbsp;</p>]]></content:encoded>
					</item>
				
					<item>
						<guid>news-6995</guid>
						<pubDate>Wed, 11 Oct 2017 09:07:00 +0000</pubDate>
						<title>Smart. Efficient. Accurate. </title>
						<link>https://www.gbo.com/en_FR/news-events/newsroom/news/news-detail/news/detail/News/smart-efficient-accurate.html</link>
						<description>New CX NIMBUS and CX STARlet instrument platforms – automated genotyping of human papillomaviruses (HPV) </description>
						<content:encoded><![CDATA[<p class="bodytext"><span style="font-weight: bold;">Frickenhausen, October 24 Greiner Bio-One, technology partner for the diagnostic and pharmaceutical industry, unveiled two new instrument platforms for the automated use of PapilloCheck at this year’s EUROGIN in Amsterdam, the international conference for education and research on the human papillomavirus (HPV). </span> The compact sized CX NIMBUS fits easily in any laboratory setting and incorporates liquid handling of DNA extraction and pre-PCR for an easy and fast processing of 48 samples. CX STARlet is used for automated processing of 96 samples with its integrated devices such as thermal cycler and sealer. The two platforms enable a faster and more efficient qualitative detection of HPV.</p>
<p class="highlighted">PapilloCheck – fast analysis, accurate results </p>
<p class="bodytext">An infection with the human papillomavirus (HPV) is the cause of virtually all cases of cervical cancer. With the CE-marked in vitro diagnostic device PapilloCheck, Greiner Bio-One can provide a test system which enables not only the detection but also the simultaneous genotyp-ing of six low-risk (lr) and 18 high-risk (hr) HPV types from cervical smears in a single analysis. Hence, whilst the test system can be used for HPV primary screening purposes it can also be a valuable tool for an improved HPV risk assessment of the patient. Furthermore, PapilloCheck plays an important role in terms of HPV vaccination management and in epidemiological studies. PapilloCheck meets the requirements in cervical cancer screening due to high clinical sensitivity, specificity, as well as reproducibility and benefits from its integrated control system which guarantees accurate results.</p>
<p class="highlighted">Boosting profitability </p>
<p class="bodytext">The new CX platforms allow laboratories to streamline the PapilloCheck workflow by integrating DNA extraction, PCR setup and microarray hybridisation. The automated sample processing out of the primary tube significantly shortens hands-on time, allows an increased throughput and helps laboratories to be more efficient and profitable.</p>]]></content:encoded>
					</item>
				
					<item>
						<guid>news-6290</guid>
						<pubDate>Fri, 05 May 2017 07:39:00 +0000</pubDate>
						<title>2016: A Strong Year for the Greiner Group</title>
						<link>https://www.gbo.com/en_FR/news-events/newsroom/news/news-detail/news/detail/News/2016-a-strong-year-for-the-greiner-group.html</link>
						<description>The Greiner Group once again improved its sales figures and reached its financial targets in the business year 2016. Besides globalization, diversification and innovation as the key factors of success, the “Plastics for Life” sustainability strategy is at the center of activities.</description>
						<content:encoded><![CDATA[<p class="bodytext">Kremsmünster, May 3, 2017 – The Greiner Group improved its consolidated sales revenues by 2.4 percent compared to the previous year to reach EUR 1.475 billion in the financial year 2016 (prev. yr.: EUR 1.441 billion). “The consistent implementation of the globalization strategy, the bundling of core competencies and the strengthening of innovative capacity in all divisions contributes decisively to the successful development,” says Chairman of the Board Axel Kühner. The cash flow could be increased to EUR 148 million (prev. yr.: EUR 132 million), which is an improvement of 12 percent compared to the previous year. All investments in the amount of EUR 101 million were financed from the cash flow (prev. yr.: EUR 94 million; +7 percent). The Greiner Group has invested worldwide in the expansion of its operating sites and the modernization of plants and machinery. “Profit-oriented growth continues to remain in the focus. The bandwidth of our portfolio lends us stability for the long-term development of our Group,” explains Hannes Moser, CFO of the Greiner Group. In the financial year 2016, the number of employees working at 134 sites around the world rose to 9,722 (prev. yr.: 9,299; +423 employees).<br />&nbsp;<br /><span class="highlighted">Globalization continues</span></p>
<p class="bodytext">Europe, accounting for rounded 75 percent of sales, is the Greiner Group’s core market, followed by North America and Asia with 10 percent each. “Tapping new markets remains a central topic. Besides the USA, we are focused on the BRICS states, as these markets will record a stronger growth than Europe in the medium to long term,” explains Kühner. In 2016, Greiner Packaging founded a joint venture with a packaging company in India. The company thereby positioned itself on the Indian market with food packaging that is used in the dairy industry. The expansion of the Greiner Bio-One production site in Brazil was completed as planned in the fall of 2016. Greiner Bio-One integrated sales and distribution for Italy into its own organization by taking over a distribution partner of many years. In addition, the company founded its own sales office in Turkey. To also be able in the future to process orders from large automobile manufacturers that are to be satisfied on a global level, Greiner Foam International founded joint ventures in China and Mexico in 2016.<br />&nbsp;<br /><span class="highlighted">“Plastics for Life” for the responsible handling of plastics</span></p>
<p class="bodytext">The Greiner Group actively lives up to its responsibility as a plastics processor. Under the title “Plastics for Life”, a Group-wide sustainability process was implemented. “Plastics make our daily lives simpler in many areas. But we also know that our products can contribute to environmental pollution if they are not disposed of correctly. We therefore want to raise awareness for the best possible handling of plastics,” Axel Kühner, Chairman of the Management Board of Greiner Group, explains. “Innovation is an important lever for sustainability. We see great potential in innovative and sustainable product solutions that deliver an added value for our customers,” CFO Hannes Moser adds. Plastics should be used anywhere where the material offers advantages over other materials, for example, by saving CO2 because of its low weight during transport. Likewise, plastic waste as a resource for manufacturing new products is a central topic in the context of the company’s sustainable orientation.<br />&nbsp;<br /><span class="highlighted">Outlook 2017</span></p>
<p class="bodytext">“In spite of difficult framework conditions, we had a good start into the financial year 2017. Especially in the foam division, we are confronted with disproportionally high raw materials prices. In light of this, we expect modest growth for 2017,” says Moser. The successfully adopted globalization strategy will also be continued in the current financial year – both by means of intense working of existing markets as well as by tapping new markets.<br />On or about May 5, 2017, Greiner Bio-One takes over 67.75 percent of shares of Vigmed Holding AB, a development and trade company for safety IV catheters located in Helsingborg, Sweden. For the first time in company history, Greiner Group takes over shares of a listed company. “Through the majority shareholding in Vigmed, Greiner Bio-One is expanding its product portfolio with IV catheters. The already existing, strong distribution network of Greiner Bio-One is to be utilized for being successful in the market with the product,” explains Chairman of the Board, Axel Kühner.<br />In the first quarter of 2017, 70 percent of the shares in Plastic System, a Russian packaging specialist with operating site in Noginsk, near Moscow, was taken over by Greiner Packaging. Greiner Packaging thus continues to expand its market share in Russia and its product portfolio. Additionally, Greiner aerospace is expanding its competency with the acquisition of CarTrim, a German specialist for cabin components of aircraft. “The integration of the new acquisitions, the expansion to new markets and the continuous implementation of the sustainability strategy in operations will keep us very busy in the current financial year,” says Kühner.<br />&nbsp;<br />The Greiner Group furthermore invests strongly in the Upper Austrian site. The groundbreaking for the expansion of the headquarters in Kremsmünster will take place in the fall of 2017. Overall EUR 16 million will be invested in the construction. Besides a new trainee center, office areas, open work spaces and the site’s own employee bistro will be built on the modern Greiner Campus. Its completion is planned for early 2019.<br />&nbsp;<br />++++</p>
<p class="bodytext"><br /><span style="font-weight: bold;">About the Greiner Group</span><br />The Greiner Group with headquarters in Kremsmünster, with its four operative business units (Greiner Packaging International GmbH, Greiner Bio-One International GmbH, Greiner Foam International GmbH, Greiner Extrusion Group GmbH) is among the leading foam producers and plastics processors for the packaging, furniture, sports and automotive industry, as well as for medical technology, the pharmaceuticals sector and the leading manufacturers of extrusion tools and machines for plant engineering. The Greiner Group earned sales revenues of EUR 1.475 billion in the financial year 2016 and employed more than 9,700 people at 134 operating sites in 30 countries. The Chairman of the Management Board of the Greiner Group is (DH) Axel Kühner (MBA), the CFO is Mag. Hannes Moser. www.greiner.at</p>]]></content:encoded>
					</item>
				
			
	</channel>
</rss>

<!-- Parsetime: 0ms -->